Intelligent Investor

Viralytics Limited (ASX: VLA) - Announcements

DELISTED - Current share price for VLA : $1.745

ASX company news and announcements for Viralytics Limited (VLA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Viralytics Limited (VLA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Viralytics Limited (VLA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Viralytics Limited (VLA)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Removal from Official List at close 21/06/2018 21 Jun 2018 9:28AM $1.745 $1.745 $1.745 fallen by 0%
- Implementation of Scheme of Arrangement 20 Jun 2018 5:36PM $1.745 $1.745 $1.745 fallen by 0%
- Suspension from Official Quotation at close 05/06/18 5 Jun 2018 1:27PM $1.748 $1.745 $1.745 fallen by 0.14%
- Lodgement of court orders with ASIC 5 Jun 2018 12:22PM $1.745 $1.745 $1.745 fallen by 0%
- Correction to Scheme of Arrangement Timetable 4 Jun 2018 2:42PM $1.748 $1.745 $1.745 fallen by 0.14%
- Federal Court of Australia approves scheme of arrangement 4 Jun 2018 12:16PM $1.748 $1.745 $1.745 fallen by 0.14%
- VLA Shareholders Vote in Favour of Scheme of Arrangement 28 May 2018 4:53PM $1.735 $1.745 $1.745 risen by 0.58%
- Shareholder Meeting Scheme of Arrangement Presentation 28 May 2018 1:38PM $1.738 $1.745 $1.745 risen by 0.43%
- Shareholder Meeting Scheme of Arrangement Chairman's Address 28 May 2018 1:37PM $1.738 $1.745 $1.745 risen by 0.43%
- Update on Scheme of Arrangement 23 May 2018 9:29AM $1.730 $1.745 $1.745 risen by 0.87%
- Appendix 4C - quarterly 24 Apr 2018 9:47AM $1.700 $1.745 $1.745 risen by 2.65%
- Court approves convening of scheme meeting 20 Apr 2018 7:23PM $1.695 $1.745 $1.745 risen by 2.95%
- New CAVATAK Data at International Oncolytic Virus Conference 11 Apr 2018 9:51AM $1.685 $1.745 $1.745 risen by 3.56%
- Ceasing to be a substantial holder from MUFG 9 Mar 2018 3:00PM $1.678 $1.745 $1.745 risen by 4.02%
- Ceasing to be a substantial holder from MS 8 Mar 2018 7:11PM $1.675 $1.745 $1.745 risen by 4.18%
- Ceasing to be a substantial holder 6 Mar 2018 8:23AM $1.675 $1.745 $1.745 risen by 4.18%
- Becoming a substantial holder from MUFG 5 Mar 2018 8:24AM $1.675 $1.745 $1.745 risen by 4.18%
- Becoming a substantial holder from MS 2 Mar 2018 6:52PM $1.675 $1.745 $1.745 risen by 4.18%
- Ceasing to be a substantial holder 2 Mar 2018 10:33AM $1.675 $1.745 $1.745 risen by 4.18%
- Appendix 4D Half Yearly Report and Accounts 26 Feb 2018 4:59PM $1.690 $1.745 $1.745 risen by 3.25%
- MSD and Viralytics Announce Acquisition Agreement 21 Feb 2018 8:20PM $0.615 $1.745 $1.745 risen by 183.74%
- Appendix 4C - quarterly 24 Jan 2018 6:14PM $0.730 $1.745 $1.745 risen by 139.04%
- Ceasing to be a substantial holder 15 Jan 2018 2:43PM $0.715 $1.745 $1.745 risen by 144.06%
- Change of Director's Interest Notice 12 Jan 2018 3:26PM $0.730 $1.745 $1.745 risen by 139.04%
- Ceasing to be a substantial holder 12 Jan 2018 9:08AM $0.740 $1.745 $1.745 risen by 135.81%

1 - 25 of 341 results

Page 1 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.